Miguel Verbitsky

ORCID: 0000-0002-7066-0552
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal and related cancers
  • Parkinson's Disease Mechanisms and Treatments
  • Nicotinic Acetylcholine Receptors Study
  • Receptor Mechanisms and Signaling
  • Pediatric Urology and Nephrology Studies
  • Genomic variations and chromosomal abnormalities
  • Renal Diseases and Glomerulopathies
  • Ion channel regulation and function
  • Genomics and Rare Diseases
  • Genetics and Neurodevelopmental Disorders
  • RNA regulation and disease
  • Neuroscience and Neuropharmacology Research
  • BRCA gene mutations in cancer
  • Autism Spectrum Disorder Research
  • Urological Disorders and Treatments
  • Chronic Kidney Disease and Diabetes
  • Prenatal Screening and Diagnostics
  • Ginkgo biloba and Cashew Applications
  • Genetic Associations and Epidemiology
  • Neuropeptides and Animal Physiology
  • Lysosomal Storage Disorders Research
  • Nuclear Receptors and Signaling
  • Neurological disorders and treatments
  • Gene expression and cancer classification
  • Cancer Genomics and Diagnostics

Columbia University
2014-2025

Columbia University Irving Medical Center
2012-2024

University of Genoa
2023

Istituto Giannina Gaslini
2023

Morgan Stanley Children's Hospital
2023

Center for Human Genetics
2010

Clark Art Institute
2009

Icahn School of Medicine at Mount Sinai
2007

New York Genome Center
2004-2005

Experimental Medicine and Biology Institute
2000-2005

To assess the cognitive phenotype of glucocerebrosidase (GBA) mutation carriers with early-onset Parkinson disease (PD).We administered a neuropsychological battery and University Pennsylvania Smell Identification Test (UPSIT) to participants in CORE-PD study who were tested for mutations PARKIN, LRRK2, GBA. Participants included 33 GBA 60 noncarriers any genetic mutation. Primary analyses performed on 26 heterozygous without additional 39 age- PD duration-matched noncarriers. Five domains,...

10.1212/wnl.0b013e318253d54b article EN Neurology 2012-03-23

10.1038/s41588-018-0281-y article EN Nature Genetics 2018-12-18

Background: The utility of whole-exome sequencing (WES) for the diagnosis and management adult-onset constitutional disorders has not been adequately studied. Genetic diagnostics may be advantageous in adults with chronic kidney disease (CKD), whom cause failure often remains unknown. Objective: To study diagnostic WES a selected referral population CKD. Design: Observational cohort. Setting: A major academic medical center. Patients: 92 CKD unknown or familial nephropathy hypertension....

10.7326/m17-1319 article EN Annals of Internal Medicine 2017-12-05

<h3>Background</h3> Mutations in the glucocerebrosidase (<i>GBA</i>) gene are associated with Lewy body (LB) disorders. <h3>Objective</h3> To determine relationship of<i>GBA</i>mutations and<i>APOE4</i>genotype to LB and Alzheimer disease (AD) pathological findings. <h3>Design</h3> Case-control study. <h3>Setting</h3> Academic research. <h3>Participants</h3> The 187 subjects included patients primary neuropathological diagnoses of disorders or without AD changes (95 cases), randomly selected...

10.1001/archneurol.2009.54 article EN Archives of Neurology 2009-05-01

Abstract Background To date, nine Parkinson disease (PD) genome-wide association studies in North American, European and Asian populations have been published. The majority of confirmed the previously identified genetic risk factors, SNCA MAPT , two three new PD susceptibility loci/genes ( PARK16, BST1 HLA-DRB5 ). In a recent meta-analysis datasets from five published GWAS an additional 6 novel candidate genes SYT11, ACMSD, STK39, MCCC1/LAMP3, GAK CCDC62/HIP1R ) were identified. Collectively...

10.1186/1471-2350-12-104 article EN cc-by BMC Medical Genetics 2011-08-03

The full complement of molecular pathways contributing to the pathogenesis Parkinson disease (PD) remains unknown. Here we address this issue by taking a broad approach, beginning using functional MRI identify brainstem regions differentially affected and resistant disease. Relying on these imaging findings, then profiled gene expression levels from postmortem regions, identifying disease-related decrease in catabolic polyamine enzyme spermidine/spermine N1-acetyltransferase 1 (SAT1). Next,...

10.1073/pnas.1011751107 article EN Proceedings of the National Academy of Sciences 2010-09-13

<h3>Objective</h3> To assess the frequency and clinical characteristics of carriers previously identified mutations in 6 genes associated with early-onset Parkinson disease (PD) provide empirical data that can be used to inform genetic counseling. <h3>Design</h3> Cross-sectional observational study. <h3>Setting</h3> Thirteen movement disorders centers. <h3>Patients</h3> Nine hundred fifty-three individuals PD defined as age at onset (AAO) younger than 51 years. Participants included 77 139...

10.1001/archneurol.2010.194 article EN Archives of Neurology 2010-09-01

The DiGeorge syndrome, the most common of microdeletion syndromes, affects multiple organs, including heart, nervous system, and kidney. It is caused by deletions on chromosome 22q11.2; genetic driver kidney defects unknown.

10.1056/nejmoa1609009 article EN New England Journal of Medicine 2017-01-25

Congenital abnormalities of the kidney and urinary tract are most common cause pediatric failure. These disorders highly heterogeneous, etiologic factors poorly understood.We performed genomewide linkage analysis whole-exome sequencing in a family with an autosomal dominant form congenital or (seven affected members). We also sequence 311 unrelated patients, as well histologic functional studies.Linkage identified five regions genome that were shared among all members. Exome single, rare,...

10.1056/nejmoa1214479 article EN New England Journal of Medicine 2013-07-17

African Americans have a significantly higher risk of developing chronic kidney disease, especially focal segmental glomerulosclerosis -, than European Americans. Two coding variants (G1 and G2) in the APOL1 gene play major role this disparity. While 13% carry high-risk recessive genotypes, only fraction these individuals develops FSGS or failure, indicating involvement additional disease modifiers. Here, we show that presence p.N264K missense variant, when co-inherited with G2 allele,...

10.1038/s41467-023-43020-9 article EN cc-by Nature Communications 2023-11-30

We have carried out a global survey of age-related changes in mRNA levels the C57BL/6NIA mouse hippocampus and found difference hippocampal gene expression profile between 2-month-old young mice 15-month-old middle-aged correlated with an cognitive deficit hippocampal-based explicit memory formation. Middle-aged displayed mild but specific spatial Morris water maze. By using Affymetrix GeneChip microarrays, we distinct pattern change, consisting mostly overexpression mice, suggesting that...

10.1101/lm.68204 article EN Learning & Memory 2004-05-01

<h3>Background</h3> Mutations in the<i>parkin</i>gene are the most common genetic cause of early-onset Parkinson disease (PD). Results from a multicenter study patients with PD systematically sampled by age at onset have not been reported to date. <h3>Objective</h3> To determine risk factors associated carrying<i>parkin</i>mutations. <h3>Design</h3> Cross-sectional observational study. <h3>Setting</h3> Thirteen movement disorders centers. <h3>Participants</h3> A total 956 PD, defined as...

10.1001/archneurol.2010.95 article EN Archives of Neurology 2010-06-01

There is frequent uncertainty in the identification of specific etiologies chronic kidney disease (CKD) children. Recent studies indicate that chromosomal microarrays can identify rare genomic imbalances clarify etiology neurodevelopmental and cardiac disorders children; however, contribution unsuspected imbalance to incidence pediatric CKD unknown.We performed detect children enrolled Chronic Kidney Disease Children (CKiD) prospective cohort study, a longitudinal multiethnic observational...

10.1172/jci80877 article EN Journal of Clinical Investigation 2015-04-19

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a poorly understood and underdiagnosed of chronic bladder/pelvic with urinary frequency urgency. Though IC/BPS can be hereditary, little known its genetic etiology. Using the eMERGE data, we confirmed phenotypic associations such as gastroesophageal reflux disease irritable bowel detected new associations, including osteoarthrosis/osteoarthritis Barretts esophagus. An exome wide ultra-rare variants analysis in 348 11,981 controls...

10.1101/2025.02.16.25322147 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2025-02-18

In the present study, we provide evidence that α9 nicotinic acetylcholine receptor (nAChR) shares pharmacological properties with members of Cys-loop family receptors. Thus, type A γ-aminobutyric acid antagonist bicuculline, glycinergic strychnine, and 3 serotonin ICS-205,930 block ACh-evoked currents in α9-injected <i>Xenopus laevis</i> oocytes following rank order potency: strychnine &gt; bicuculline. Block by antagonists was reflected an increase (ACh) EC<sub>50</sub> value, no changes...

10.1124/mol.55.2.248 article EN Molecular Pharmacology 1999-02-01

Background: A family history of health conditions may reflect shared genetic and/or environmental risk. It is not well known to what extent impacts outcomes among patients with chronic kidney disease (CKD). Herein, we studied the associations CKD, diabetes, and other common comorbidities progression CKD. Methods: We carried out an observational study two prospective CKD cohorts, 2,573 adults children from Cure Glomerulopathy Network (CureGN) 3,939 Chronic Renal Insufficiency Cohort (CRIC)...

10.1681/asn.0000000653 article EN Journal of the American Society of Nephrology 2025-03-11

Aberrant O-glycosylation of the IgA1 hinge region is a characteristic finding in patients with IgA nephropathy (IgAN) and thought to contribute immune-complex formation kidney injury. Other studies have suggested that abnormalities mucosal immunity lymphocyte homing are major contributors disease. We identified family IgAN segregating heterozygous predicted loss-of-function (LOF) variant GALNT14, gene encoding N-acetylgalactosaminyltransferase 14, one enzymes involved mucin-type protein...

10.1172/jci181164 article EN cc-by Journal of Clinical Investigation 2025-03-18
Coming Soon ...